Maravai LifeSciences Holdings, - stock earnings
MRVI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -106.0 million USD | 74.1 million USD |
| 2023Q3 | -6.5 million USD | 66.9 million USD |
| 2023Q2 | -6.5 million USD | 68.9 million USD |
| 2023Q1 | -1.3 million USD | 79.0 million USD |
| 2022Q4 | 87.4 million USD | 204.7 million USD |
| 2022Q3 | 99.7 million USD | 191.3 million USD |
| 2022Q2 | 156.7 million USD | 242.7 million USD |
| 2022Q1 | 146.9 million USD | 244.3 million USD |
| 2021Q4 | 55.8 million USD | 228.4 million USD |
| 2021Q3 | 54.3 million USD | 204.8 million USD |
| 2021Q2 | 49.1 million USD | 217.8 million USD |
| 2021Q1 | 23.2 million USD | 148.2 million USD |
| 2020Q4 | 25.2 million USD | 98.4 million USD |
| 2020Q3 | 39.0 million USD | 87.9 million USD |
| 2020Q2 | 207000 USD | 46.9 million USD |
| 2020Q1 | 23.4 million USD | 51.0 million USD |
| 2019Q4 | -5.4 million USD | 36.0 million USD |
MRVI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -119.0 million USD | 288.9 million USD |
| 2022 | 490.7 million USD | 883.0 million USD |
| 2021 | 469.3 million USD | 799.2 million USD |
| 2020 | 76.9 million USD | 284.1 million USD |
| 2019 | -5.2 million USD | 143.1 million USD |
| 2018 | -17.7 million USD | 123.8 million USD |
MRVI
Price: $8.97
52 week price:
Earnings Per Share: -0.90 USD
P/E Ratio: 30.44
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Market Capitalization: 2.0 billion